Abstract:Edaravone dexborneol is a novel neuroprotective drug that comprises edaravone and (+)-borneol in a 4:1 ratio. Phase II and III studies have demonstrated that Chinese patients treated with edaravone dexborneol within 48 h of AIS onset have better functional outcomes than those treated with edaravone alone. However, the effect of edaravone dexborneol on subarachnoid hemorrhage (SAH) has not yet been elucidated. This study aimed to investigate the therapeutic effects of edaravone dexborneol on SAH-induced brain injury and long-term behavioral deficits and to explore the possible mechanisms. The experimental rat SAH model was induced by an intraluminal puncture of the left middle cerebral artery (MCA). Edaravone dexborneol or edaravone at a clinical dose was infused into the tail vein for 3 days post-SAH surgery. Behavioral outcomes were assessed by a modified Garcia scoring system and rotarod, foot-fault, and corner tests. Immunofluorescence, Western blot, and ELISA methods were used to evaluate neuronal damage and oxidative stress. Our results showed that a post-SAH therapeutic regimen with edaravone dexborneol helped improve neurological function up to 21 days after SAH surgery and demonstrated a greater beneficial effect than edaravone alone, accompanied by an obvious inhibition of neuronal apoptosis in the CA1 hippocampus and basal cortex regions. Mechanistically, edaravone dexborneol not only suppressed the lipid peroxidation product malondialdehyde (MDA) but also improved the total antioxidant capability (TAC) 3 days after SAH. Notably, edaravone dexborneol treatment significantly inhibited the expression of another lipid peroxidation product, 4-hydroxynonenal (4-HNE), in the CA1 hippocampus and basal cortex, which are vital participants in the process of neuronal oxidative damage and death after SAH because of their acute cytotoxicity. Together, our results demonstrate that edaravone dexborneol confers neuroprotection and stabilizes long-term behavioral ability after SAH injury, possibly by suppressing 4-HNE-associated oxidative stress. These results may help develop new clinical strategies for SAH treatment.

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease.

Neuroprotective effect of edaravone on focal cerebral ischemia in rats

Edaravone Protects Primary-Cultured Rat Cortical Neurons from Ketamine-Induced Apoptosis Via Reducing Oxidative Stress and Activating PI3K/Akt Signal Pathway

Edaravone's free radical scavenging mechanisms of neuroprotection against cerebral ischemia: review of the literature

Ellagic Acid Protects Dopamine Neurons from Rotenone‐induced Neurotoxicity Via Activation of Nrf2 Signalling

Edaravone Protects Cortical Neurons from Apoptosis by Inhibiting the Translocation of Bax and Increasing the Interaction Between 14-3-3 and P-Bad

Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats

Protective Effect of Edaravone on Ventilator Induced Lung Injury in Rats

Protective Effect of Edaravone Against Alzheimer's Disease-Relevant Insults in Neuroblastoma N2a Cells

Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model

Edaravone dexborneol attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory responses and modulating the NMDA receptor signaling pathway

Edaravone attenuates H2O2 or glutamate-induced toxicity in hippocampal neurons and improves AlCl3/D-galactose induced cognitive impairment in mice

Protective Effect of Edaravone in Primary Cerebellar Granule Neurons against Iodoacetic Acid-Induced Cell Injury

Ecklonia cava Polyphenols Have a Preventive Effect on Parkinson's Disease through the Activation of the Nrf2-ARE Pathway

Edaravone Dexborneol Alleviates Neuroinflammation by Reducing Neuroglial Cell Proliferation and Suppresses Neuronal Apoptosis/Autophagy in Vascular Dementia Rats

Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation

Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage

Pre- and Post-Treatment with Edaravone Protects CA1 Hippocampus and Enhances Neurogenesis in the Subgranular Zone of Dentate Gyrus after Transient Global Cerebral Ischemia in Rats

Treatment with Edaravone Attenuates Ischemic Brain Injury and Inhibits Neurogenesis in the Subventricular Zone of Adult Rats after Focal Cerebral Ischemia and Reperfusion Injury

Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice

Expanding Applications in Neurodegenerative Diseases